Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Breeze Meds vs Get Thin MD

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.3

Breeze Meds

Best for compounded GLP-1 access with named prescribers and 4-pharmacy network
★★★3.7

Starting at $199/mo

CompoundedSemaglutideTirzepatideAll 50 States
Visit Breeze Meds
7.9

Get Thin MD

Best for lowest-priced compounded semaglutide on a 3-month commitment, with brand-name Ozempic/Zepbound also available
★★★★4

Starting at $169/mo

CompoundedSemaglutideTirzepatideBrand
Visit Get Thin MD

Side-by-Side Comparison

FeatureBreeze MedsGet Thin MD
Overall Score7.3/107.9/10
Starting Price$199/mo$169/mo
Editorial Rating3.7 ★ /54 ★ /5
Features6 features7 features
States Available00
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Breeze Meds

Pros

  • Available in all 50 US states
  • LegitScript certified seal displayed in footer
  • Publicly named medical team with NPI numbers: Dr. Ana Lisa Carr MD (NPI 1689841744) and Dr. Kelly Tenbrink MD (NPI 1346482684)
  • Four named 503A pharmacy partners: Belmar Pharma Solutions, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx
  • Both injectable and oral formats available for semaglutide and tirzepatide
  • No FDA warning letters or litigation on record as of 2026-04-09

Cons

  • Runs on the same Lion MD clinician network and the same 4 compounding pharmacies as Care Bare Rx and Synergy Rx — if you're comparing the three brands, be aware you're comparing three storefronts on top of one underlying operation, not three independent providers
  • Compounded medications are not FDA-approved
  • Compounded vs. brand-name drug sourcing is ambiguously disclosed on the product pages
  • Terms of Service page returns a 404 (Privacy Policy is present) — a procedural transparency gap
  • Insurance acceptance is not clearly disclosed beyond FSA/HSA eligibility

Get Thin MD

Pros

  • 3-month compounded semaglutide plan at $169/month is one of the lowest ongoing prices in the compounded GLP-1 category
  • Price-lock positioning: 'Same price, every dose. No hidden fees.' — per the product page
  • Both compounded and brand-name options available in one platform (compounded semaglutide, compounded tirzepatide, plus brand-name Ozempic and Zepbound where medically appropriate)
  • Nationwide availability with async evaluation — no in-person visit required
  • Broader wellness platform that also offers sermorelin, NAD+, HRT, and hair-loss treatments, so patients can consolidate multiple protocols with one provider
  • Proper FDA compounding disclaimer on the product page: "The FDA does not review or approve any compounded medications for safety or effectiveness."

Cons

  • Compounded medications are not FDA-approved as finished products and lack the formal safety/efficacy review of brand-name Ozempic, Wegovy, Zepbound, and Mounjaro
  • Pharmacy partners not publicly named on the site — no independent way to verify 503A/503B compounding source or per-batch testing
  • State-by-state availability claimed as nationwide but no verbatim state list is published — needs intake signup to confirm whether every state is actually served
  • Clinical efficacy headline ("9.6 pounds in 30 days") is based on 645 self-reported patient data points from Jan 2024 – Apr 2025 — self-reported data is lower-quality than a randomized trial
  • Broader wellness funnel (sermorelin + NAD+ + HRT alongside GLP-1s) means some patients may be upsold into off-weight-loss protocols — readers looking specifically for GLP-1 care should know the platform has a wider vertical mix

Our Verdict

Winner: Get Thin MDScore: 7.9/10

Get Thin MD edges out Breeze Meds with a higher overall score of 7.9/10 and is particularly strong for lowest-priced compounded semaglutide on a 3-month commitment, with brand-name Ozempic/Zepbound also available. Breeze Meds remains a solid alternative, especially if you're looking for compounded GLP-1 access with named prescribers and 4-pharmacy network.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.